Self-identified Black Race as a Risk Factor for Intraocular Pressure Elevation and Iritis Following Prophylactic Laser Peripheral Iridotomy.


Journal

Journal of glaucoma
ISSN: 1536-481X
Titre abrégé: J Glaucoma
Pays: United States
ID NLM: 9300903

Informations de publication

Date de publication:
01 04 2022
Historique:
received: 12 08 2021
accepted: 27 12 2021
pubmed: 9 2 2022
medline: 2 4 2022
entrez: 8 2 2022
Statut: ppublish

Résumé

In primary angle closure suspects (PACS), self-identified Black race was a risk factor for intraocular pressure (IOP) elevation and iritis following laser peripheral iridotomy (LPI). Laser type was not associated with either immediate post-LPI IOP elevation or iritis in multivariate analysis. The aim was to determine the impact of laser type and patient characteristics on the incidence of IOP elevation and iritis after LPI in PACS. The electronic medical records of 1485 PACS (2407 eyes) who underwent either neodymium-doped yttrium-aluminum-garnet or sequential argon and neodymium-doped yttrium-aluminum-garnet LPI at the University of Pennsylvania between 2010 and 2018 were retrospectively reviewed. Average IOP within 30 days before LPI (baseline IOP), post-LPI IOP within 1 hour, laser type, laser energy, and the incidence of new iritis within 30 days following the procedure were collected. Multivariate logistic regression accounting for intereye correlation was used to assess factors associated with incidence of post-LPI IOP elevation and iritis, adjusted by age, sex, surgeon, and histories of autoimmune disease, diabetes, and hypertension. The incidence of post-LPI IOP elevation and iritis were 9.3% (95% confidence interval: 8.1%-10.5%) and 2.6% (95% CI: 1.9%-3.2%), respectively. In multivariate analysis, self-identified Black race was a risk factor for both IOP elevation [odds ratio (OR): 2.08 compared with White; P=0.002] and iritis (OR: 5.07; P<0.001). Higher baseline IOP was associated with increased risk for post-LPI IOP elevation (OR: 1.19; P<0.001). Laser type and energy were not associated with either post-LPI IOP elevation or iritis (P>0.11 for all). The incidence of immediate IOP elevation and iritis following prophylactic LPI was higher in Black patients independent of laser type and energy. Heightened vigilance and increased medication management before and after the procedure are suggested to help mitigate these risks.

Identifiants

pubmed: 35131983
doi: 10.1097/IJG.0000000000001995
pii: 00061198-202204000-00002
pmc: PMC8963523
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

218-223

Subventions

Organisme : NEI NIH HHS
ID : L30 EY029353
Pays : United States
Organisme : NHLBI NIH HHS
ID : R25 HL084665
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY001583
Pays : United States
Organisme : NEI NIH HHS
ID : K12 EY015398
Pays : United States
Organisme : NEI NIH HHS
ID : K08 EY029765
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

Disclosure: The authors declare no conflict of interest.

Références

Quigley HA. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267.
Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–2090.
Sun X, Dai Y, Chen Y, et al. Primary angle closure glaucoma: what we know and what we don’t know. Prog Retin Eye Res. 2017;57:26–45.
Chen TC, Ang RT, Grosskreutz CL, et al. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery. Ophthalmology. 2001;108:1033–1038.
Radhakrishnan S, Chen PP, Junk AK, et al. Laser peripheral iridotomy in primary angle closure: a report by the American Academy of Ophthalmology. Ophthalmology. 2018;125:1110–1120.
Robin AL, Pollack IP. A comparison of neodymium:YAG and argon laser iridotomies. Ophthalmology. 1984;91:1011–1016.
Siam GA, Monteiro De Barros DS, Gheith ME, et al. Post-peripheral iridotomy inflammation in patients with dark pigmentation. Ophthalmic Surg Lasers Imaging. 2008;39:49–53.
Neatrour K, McAlpine A, Owens TB, et al. Evaluation of the etiology of persistent iritis after cataract surgery. J Ophthalmic Inflamm Infect. 2019;9:4.
Ali A, Rosenfeld C, Rosenberg E, et al. Chronic uveitis following neodymium-doped yttrium aluminum garnet laser peripheral iridotomy. J Glaucoma. 2017;26:e229–e231.
Sng CCA, Barton K. Mechanism and management of angle closure in uveitis. Curr Opin Ophthalmol. 2015;26:122–127.
Fleck BW, Dhillon B, Khanna V, et al. A randomised, prospective comparison of Nd:YAG laser iridotomy and operative peripheral iridectomy in fellow eyes. Eye Basingstoke. 1991;5:315–321.
Moster MR, Schwartz LW, Spaeth GL, et al. Laser iridectomy: a controlled study comparing argon and neodymium:YAG. Ophthalmology. 1986;93:20–24.
Ho T, Fan R. Sequential argon-YAG laser iridotomies in dark irides. Br J Ophthalmol. 1992;76:329–331.
Del Priore LV, Robin AL, Pollack IP. Neodymium:YAG and argon laser iridotomy: long-term follow-up in a prospective, randomized clinical trial. Ophthalmology. 1988;95:1207–1211.
Harada T, Mizuno K, Horiguchi M. Use of Nd:YAG laser as adjunct to argon laser iridotomy. Jpn J Clin Ophthalmol. 1989;43:265–269.
Goins K, Schmeisser E, Smith T. Argon laser pretreatment in Nd:YAG iridotomy. Ophthalmic Surg. 1990;21:497–500.
Kam JP, Zepeda EM, Ding L, et al. Resident-performed laser peripheral iridotomy in primary angle closure, primary angle closure suspects, and primary angle closure glaucoma. Clin Ophthalmol. 2017;11:1871–1876.
Jiang Y, Chang DS, Foster PJ, et al. Immediate changes in intraocular pressure after laser peripheral iridotomy in primary angle-closure suspects. Ophthalmology. 2012;119:283–288.
Lee TL, Ng JY, Nongpiur ME, et al. Intraocular pressure spikes after a sequential laser peripheral iridotomy for angle closure. J Glaucoma. 2014;23:644–648.
Ahmadi M, Naderi Beni Z, Naderi Beni A, et al. Efficacy of neodymium-doped yttrium aluminum garnet laser iridotomies in primary angle-closure diseases: superior peripheral iridotomy versus inferior peripheral iridotomy. Curr Med Res Opin. 2017;33:687–692.
Waisbourd M, Shafa A, Delvadia R, et al. Bilateral same-day laser peripheral iridotomy in the Philadelphia glaucoma detection and treatment project. J Glaucoma. 2016;25:e821–e825.
Agulto MB, Margaret K, Bacsal E, et al. A prospective, randomized comparison of Nd:YAG and sequential argon-YAG laser iridotomy in Filipino eyes. Philipp J Ophthalmol. 2004;29:131–135.
Vera V, Naqi A, Belovay GW, et al. Dysphotopsia after temporal versus superior laser peripheral iridotomy: a prospective randomized paired eye trial. Am J Ophthalmol. 2014;157:929–935.
Kumar RS, Baskaran M, Friedman DS, et al. Effect of prophylactic laser iridotomy on corneal endothelial cell density over 3 years in primary angle closure suspects. Br J Ophthalmol. 2013;97:258–261.
Ying GS, Maguire MG, Glynn RJ, et al. Tutorial on biostatistics: longitudinal analysis of correlated continuous eye data. Ophthalmic Epidemiol. 2021;28:3–20.
Chun YS, Park IK, Lee HIl, et al. Iris and trabecular meshwork pigment changes after posterior chamber phakic intraocular lens implantation. J Cataract Refract Surg. 2006;32:1452–1458.
Chang SHL, Lim G. Secondary pigmentary glaucoma associated with piggyback intraocular lens implantation. J Cataract Refract Surg. 2004;30:2219–2222.
Chang SHL, Wu WC, Wu SC. Late-onset secondary pigmentary glaucoma following foldable intraocular lenses implantation in the ciliary sulcus: a long-term follow-up study. BMC Ophthalmol. 2013;13:22.
Di Pippo M, Ciancimino C, Scuderi L, et al. An iconic case of pigmentary glaucoma: brief review of the literature. Case Rep Ophthalmol. 2020;11:377–384.
Thompson AC, Vu DM, Cowan LA, et al. Risk factors associated with missed diagnoses of narrow angles by the Van Herick technique. Ophthalmol Glaucoma. 2018;1:108–114.
Leung CKS, Palmiero PM, Weinreb RN, et al. Comparisons of anterior segment biometry between Chinese and Caucasians using anterior segment optical coherence tomography. Br J Ophthalmol. 2010;94:1184–1189.
Liao C, Zhang J, Jiang Y, et al. Long-term effect of YAG laser iridotomy on corneal endothelium in primary angle closure suspects: a 72-month randomised controlled study. Br J Ophthalmol. 2021;105:348–353.
Bhargava R, Kumar P, Phogat H, et al. Neodymium-yttrium aluminium garnet laser capsulotomy energy levels for posterior capsule opacification. J Ophthalmic Vis Res. 2015;10:37–42.
De Silva DJ, Gazzard G, Foster P. Laser iridotomy in dark irides. Br J Ophthalmol. 2007;91:222–225.
Shani L, David R, Tessler Z, et al. Intraocular pressure after neodymium:YAG laser treatments in the anterior segment. J Cataract Refract Surg. 1994;20:455–458.

Auteurs

Modupe O Adetunji (MO)

Department of Ophthalmology, Scheie Eye Institute.

Elana Meer (E)

Department of Ophthalmology, Scheie Eye Institute.

Gideon Whitehead (G)

Department of Ophthalmology, Scheie Eye Institute.

Peiying Hua (P)

Department of Ophthalmology, Scheie Eye Institute.
Department of Ophthalmology, Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania Perelman School of Medicine.

Avni Badami (A)

Department of Ophthalmology, Scheie Eye Institute.

Victoria Addis (V)

Department of Ophthalmology, Scheie Eye Institute.

Thomasine Gorry (T)

Department of Ophthalmology, Scheie Eye Institute.

Amanda Lehman (A)

Philadelphia Veterans Affairs Medical Center, Philadelphia, PA.

Prithvi S Sankar (PS)

Department of Ophthalmology, Scheie Eye Institute.

Eydie Miller-Ellis (E)

Department of Ophthalmology, Scheie Eye Institute.

Gui-Shuang Ying (GS)

Department of Ophthalmology, Scheie Eye Institute.
Department of Ophthalmology, Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania Perelman School of Medicine.

Qi N Cui (QN)

Department of Ophthalmology, Scheie Eye Institute.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH